Unique ID issued by UMIN | UMIN000044572 |
---|---|
Receipt number | R000050914 |
Scientific Title | A prospective clinical trial to clarify the usefulness of re-intervention after placement of multiple metal stents using a device for inducing a stent delivery system with a function for expansion. |
Date of disclosure of the study information | 2021/06/25 |
Last modified on | 2021/12/09 09:34:34 |
A prospective clinical trial to clarify the usefulness of re-intervention after placement of multiple metal stents using a device for inducing a stent delivery system with a function for expansion.
A prospective clinical trial to clarify the usefulness of re-intervention after placement of multiple metal stents using a device for inducing a stent delivery system with a function for expansion.
A prospective clinical trial to clarify the usefulness of re-intervention after placement of multiple metal stents using a device for inducing a stent delivery system with a function for expansion.
A prospective clinical trial to clarify the usefulness of re-intervention after placement of multiple metal stents using a device for inducing a stent delivery system with a function for expansion.
Japan |
Obstructive jaundice
Hepato-biliary-pancreatic medicine |
Malignancy
NO
When the metal stent is occluded, it is necessary to perform the stent placement endoscopically again, but it is often difficult to re-place the stent. Against this background, a stent delivery system induction device with extended function has become available in Japan, and the purpose is to prospectively examine cases in which retreatment was performed after stent occlusion and clarify the results.
Efficacy
Primary endpoint: Success rate of procedure
The success rate of the procedure in this study is based on the case where stent placement can be finally performed using EndoSheather.
Secondary endpoints: clinical response rate, type and frequency of complications
The clinical effect should be improved by T-bil <1.3 mg / dL or 50% or more of preoperative T-Bil. Early complications are complications that occur within 30 days, and late complications are complications that occur after that.
Interventional
Single arm
Non-randomized
Open -no one is blinded
Self control
1
Prevention
Device,equipment |
Period from the date of permission to conduct research to April 30, 2023
20 | years-old | <= |
Not applicable |
Male and Female
20 years old and over
Obstructive jaundice case
Cases where there was an offer to refuse participation
20
1st name | miyano |
Middle name | |
Last name | akira |
Osaka Medical and Pharmaceutical University
Department of Gastroenterology
569-8686
2-7 Daigaku-machi, Takatsuki, Osaka, JAPAN
072-683-1221
akira.miyano@opmu.ac.jp
1st name | miyano |
Middle name | |
Last name | akira |
Osaka Medical and Pharmaceutical University
Department of Gastroenterology
569-8686
2-7 Daigaku-machi, Takatsuki, Osaka, JAPAN
072-683-1221
akira.miyano@opmu.ac.jp
Other
Osaka Medical and Pharmaceutical University
Other
Osaka Medical and Pharmaceutical University
2-7 Daigaku-machi, Takatsuki, Osaka, JAPAN
072-683-1221
akira.miyano@opmu.ac.jp
NO
2021 | Year | 06 | Month | 25 | Day |
Unpublished
Open public recruiting
2021 | Year | 06 | Month | 17 | Day |
2021 | Year | 09 | Month | 24 | Day |
2021 | Year | 07 | Month | 01 | Day |
2023 | Year | 04 | Month | 30 | Day |
2021 | Year | 06 | Month | 17 | Day |
2021 | Year | 12 | Month | 09 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000050914